Jenoptik (JEN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Revenue declined 4.9% year-over-year to €243.6m, mainly due to weaker semiconductor sector demand.
EBITDA fell 18.6% to €36.2m, with margin at 14.9% (prior year: 17.4%).
Order intake dropped 15.5% to €204.6m; book-to-bill ratio at 0.84 (prior year: 0.94).
Free cash flow improved 48.5% to €28.9m; equity ratio rose to 57.7%.
Streamlined organizational structure implemented in 2024/2025 to enhance customer focus and efficiency.
Financial highlights
Revenue for Q1 2025 was €243.6m, down 4.9% year-over-year; 72.7% of revenue generated abroad.
EBIT dropped 35% to €16.9m; EBIT margin reduced to 6.9% (prior year: 10.2%).
Earnings after tax decreased 40.4% to €9.2m; EPS at €0.16 (down 40.7%).
Operating cash flow rose to €45.1m (prior year: €32.3m).
Net debt reduced to €382.2m from €395.5m at year-end 2024.
Outlook and guidance
Revenue for 2025 expected to be at prior-year level (+/-5%), with EBITDA margin between 18.0% and 21.0%.
Capital expenditure for 2025 forecasted significantly below 2024's €114.6m.
Upturn in semiconductor equipment industry anticipated in H2 2025, but risks from tariffs and global uncertainty remain.
Outlook reflects high market uncertainties, including tariff discussions and geopolitical risks.
Latest events from Jenoptik
- Revenue and earnings up, 2024 guidance confirmed amid robust semiconductor demand.JEN
Q2 20241 Feb 2026 - Revenue and EBITDA rose, but 2025 targets postponed to 2026 amid industry delays.JEN
Q3 202415 Jan 2026 - Revenue and profit fell in H1 2025, with guidance cut amid ongoing global uncertainties.JEN
Q2 20256 Jan 2026 - 2024 saw strong growth and margins, but 2025 outlook is cautious amid persistent uncertainties.JEN
Q4 20243 Dec 2025 - Revenue and EBITDA fell, but free cash flow and order intake improved amid market uncertainty.JEN
Q3 202512 Nov 2025 - Record revenue and EBITDA in 2024, led by semiconductor growth, despite market headwinds.JEN
Q4 2024 TU5 Jun 2025